Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleResearch and Reports

Antibiotics and Bacterial Mechanisms of Resistance

Lucas T. Schulz and Ronald E. Kendall
American Society for Clinical Laboratory Science April 2018, 31 (2) 75-80; DOI: https://doi.org/10.29074/ascls.2018000448
Lucas T. Schulz
University of Wisconsin Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald E. Kendall
Henry Ford Health System
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Mechanisms of antimicrobial resistance

    Target SiteMovement Across MembraneOther
    Target site alterationIntracellular effluxMetabolic process circumvention
    Target site protectionDecreased permeabilityAntimicrobial requisition
    Target site overproductionEnzymatic alteration
    • View popup
    Table 2.

    Classification schemes of β-lactamase enzymes. Modified from Bush and Jacoby23

    Ambler ClassificationABCD
    β-lactamasePenicillinaseMetallo β-lactamaseCephalosporinaseOxacillinase
    Bush/Jacoby classification*PC1, TEM, SHV, VEB, PER, PSE,CARB, RTGIMP, VIM, NDM, IND, L1, CAU, GOB,FEZAmpC, ACT, CMY, FOX, MIR, CMYOXA
    Common phenotypeExtended-spectrum β-lactamasesCarbapenemasesExtendedspectrum β- lactamasesCarbapenemases
    • ↵* Bolded enzymes in the Bush/Jacoby column are clinically important.

PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 31 (2)
American Society for Clinical Laboratory Science
Vol. 31, Issue 2
1 Apr 2018
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antibiotics and Bacterial Mechanisms of Resistance
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Antibiotics and Bacterial Mechanisms of Resistance
Lucas T. Schulz, Ronald E. Kendall
American Society for Clinical Laboratory Science Apr 2018, 31 (2) 75-80; DOI: 10.29074/ascls.2018000448

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Antibiotics and Bacterial Mechanisms of Resistance
Lucas T. Schulz, Ronald E. Kendall
American Society for Clinical Laboratory Science Apr 2018, 31 (2) 75-80; DOI: 10.29074/ascls.2018000448
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • LEARNING OBJECTIVES:
    • ABSTRACT
    • INTRODUCTION
    • ANTIMICROBIAL RESISTANCE MECHANISMS
    • NEW ANTIBIOTICS’ ROLE IN TREATING ANTIBIOTIC-RESISTANT BACTERIA
    • NEW β-LACTAMASE INHIBITOR ANTIBIOTICS
    • NEW TETRACYCLINE-BASED ANTIBIOTICS: OMADACYCLINE AND ERAVACYCLINE
    • NEW AMINOGLYCOSIDE ANTIBIOTIC: PLAZOMICIN
    • SUMMARY
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Barriers to Implementation of Quality Management Systems in Laboratories: Lessons from the Southern Africa TB Health Systems Project
  • Polyagglutination: Lectin Isolation for T-Activated Red Cells
  • Strength of Direct Antiglobulin Test as an Indicator of Disease Severity in Autoimmune Hemolytic Anemia
Show more Research and Reports

Similar Articles

Keywords

  • AMEs - aminoglycoside-modifying enzymes
  • BL - β-lactam
  • BLIs - β-lactamase inhibitors
  • CDC - Centers for Disease Control and Prevention
  • CRE - carbapenem-resistant Enterobacteriaceae
  • ESBL - extended-spectrum β-lactamase producing Enterobacteriaceae
  • FDA - US Food and Drug Administration
  • IDSA - Infectious Diseases Society of America
  • MDR - multidrug resistant
  • MICs - minimum inhibitory concentrations
  • MRSA - methicillin-resistant Staphylococcus aureus
  • PBP - penicillin-binding protein
  • VRE - vancomycin-resistant Enterococcus
  • WHO - World Health Organization
  • antimicrobial resistance
  • beta-lactamases
  • vaborbactam
  • relebactam
  • omadacycline
  • eravacycline
  • plazomicin

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire